UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial

American journal of kidney diseases, 2016-07, Vol.68 (1), p.84-93

2016

Volltextzugriff (PDF)

Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study

BMC nephrology, 2019-04, Vol.20 (1), p.125-12, Article 125

2019

Volltextzugriff (PDF)

Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysis

Transplant international, 2017-12, Vol.30 (12), p.1275-1283

2017

Volltextzugriff (PDF)

5‐Year outcomes of the prospective and randomized CISTCERT study comparing steroid withdrawal to replacement of cyclosporine with everolimus in de novo kidney transplant patients

Transplant international, 2021-02, Vol.34 (2), p.313-326

2021

Volltextzugriff (PDF)

Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational study

Clinical Kidney Journal, 2019-04, Vol.12 (2), p.196-205

2019

Volltextzugriff (PDF)

Eculizumab Prevents Thrombotic Microangiopathy: Long-Term Follow-up Study of Patients with Atypical Hemolytic Uremic Syndrome

Blood, 2015-12, Vol.126 (23), p.2252-2252

2015

Volltextzugriff (PDF)

SO050LONG-TERM FOLLOW-UP STUDY OF ECULIZUMAB FOR PREVENTION OF THROMBOTIC MICROANGIOPATHY IN PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME

Nephrology, dialysis, transplantation, 2016-05, Vol.31 (suppl_1), p.i84-i84

2016

Volltextzugriff (PDF)

Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational study

Clinical kidney journal, 2019-04, Vol.12 (2), p.196

2019

Volltextzugriff (PDF)

Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min)

Nephrology, dialysis, transplantation, 2015-05, Vol.30 Suppl 2 (suppl 2), p.ii1-ii142

2015

Volltextzugriff (PDF)

Outcome of the living kidney donor

Nephrology, dialysis, transplantation, 2012, Vol.27 (1), p.41-50

2012

Volltextzugriff (PDF)

Allogeneic mesenchymal stromal cell therapy in kidney transplantation: should repeated human leukocyte antigen mismatches be avoided?

Frontiers in genetics, 2024-09, Vol.15

2024

Volltextzugriff (PDF)

The MHC class I MICA gene is a histocompatibility antigen in kidney transplantation

Nature Medicine, 2022-05, Vol.28 (5), p.989-998

2022

Volltextzugriff (PDF)

Recurrence and Outcome of Anti−Glomerular Basement Membrane Glomerulonephritis After Kidney Transplantation

Kidney international reports, 2021-07, Vol.6 (7), p.1888-1894

2021

Volltextzugriff (PDF)

Delayed Graft Function Does Not Harm the Future of Donation-After-Cardiac Death in Kidney Transplantation

Transplantation proceedings, 2012-11, Vol.44 (9), p.2795-2802

2012

Volltextzugriff (PDF)

A More Than 20% Increase in Deceased-Donor Organ Procurement and Transplantation Activity After the Use of Donation After Circulatory Death

Transplantation proceedings, 2014, Vol.46 (1), p.9-13

2014

Volltextzugriff (PDF)

Belgian consensus statement on the diagnosis and management of patients with atypical hemolytic uremic syndrome

Acta clinica belgica (English ed. Online), 2018-02, Vol.73 (1), p.80-89

2018

Volltextzugriff (PDF)

Evolution of Native Kidney Function After Pancreas Transplantation Alone

Transplantation proceedings, 2012-11, Vol.44 (9), p.2829-2833

2012

Volltextzugriff (PDF)

A Retrospective Monocenter Review of Simultaneous Pancreas-Kidney Transplantation

Transplantation proceedings, 2009-10, Vol.41 (8), p.3389-3392

2009

Volltextzugriff (PDF)

Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis

Clinical kidney journal, 2014-06, Vol.7 (3), p.282-285

2014

Volltextzugriff (PDF)

Injection of sulbutiamine induces an increase in thiamine triphosphate in rat tissues

Biochemical pharmacology, 1990-12, Vol.40 (11), p.2557-2560

1990

Volltextzugriff (PDF)

Comparable transplant outcomes between DBD and DCD kidney grafts up to 5 years post-transplant: single centre experience

2015

Volltextzugriff (PDF)

1 – 21 von 21

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(21)
Mit Volltextzugriff
(20)

Publikationsform

Artikel
(20)
Webseiten
(1)

Sprache

Englisch
(21)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Terminal Complement Inhibitor Eculizumab in Adult Patients With Atypical Hemolytic Uremic Syndrome: A Single-Arm, Open-Label Trial

Outcomes in patients with atypical hemolytic uremic syndrome treated with eculizumab in a long-term observational study

Outcomes of patients with atypical haemolytic uraemic syndrome with native and transplanted kidneys treated with eculizumab: a pooled post hoc analysis

5‐Year outcomes of the prospective and randomized CISTCERT study comparing steroid withdrawal to replacement of cyclosporine with everolimus in de novo kidney transplant patients

Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational study

Eculizumab Prevents Thrombotic Microangiopathy: Long-Term Follow-up Study of Patients with Atypical Hemolytic Uremic Syndrome

SO050LONG-TERM FOLLOW-UP STUDY OF ECULIZUMAB FOR PREVENTION OF THROMBOTIC MICROANGIOPATHY IN PATIENTS WITH ATYPICAL HEMOLYTIC UREMIC SYNDROME

Eculizumab prevents thrombotic microangiopathy in patients with atypical haemolytic uraemic syndrome in a long-term observational study

Clinical Practice Guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL/min)

Outcome of the living kidney donor

Allogeneic mesenchymal stromal cell therapy in kidney transplantation: should repeated human leukocyte antigen mismatches be avoided?

The MHC class I MICA gene is a histocompatibility antigen in kidney transplantation

Recurrence and Outcome of Anti−Glomerular Basement Membrane Glomerulonephritis After Kidney Transplantation

Delayed Graft Function Does Not Harm the Future of Donation-After-Cardiac Death in Kidney Transplantation

A More Than 20% Increase in Deceased-Donor Organ Procurement and Transplantation Activity After the Use of Donation After Circulatory Death

Belgian consensus statement on the diagnosis and management of patients with atypical hemolytic uremic syndrome

Evolution of Native Kidney Function After Pancreas Transplantation Alone

A Retrospective Monocenter Review of Simultaneous Pancreas-Kidney Transplantation

Two novel mutations of the CLDN16 gene cause familial hypomagnesaemia with hypercalciuria and nephrocalcinosis

Injection of sulbutiamine induces an increase in thiamine triphosphate in rat tissues

Comparable transplant outcomes between DBD and DCD kidney grafts up to 5 years post-transplant: single centre experience

Suchergebnisse filtern